MedTrace Logo

D-dimer to Improve Anticoagulation Outcome During ECMO loNg-term supporteD

NCT03261284 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2023-04-18

No results posted yet for this study

Summary

This was a prospective, cohort study.

Conditions

Interventions

DIAGNOSTIC_TEST

D-dimer-guided adjustment stratege

D-dimer-guided adjustment stratege

DIAGNOSTIC_TEST

Thepeautic-heparin therapy

0.3-0.7U/ml of anti-Xa activity or APTT 1.5-2.5 times of control

Sponsors & Collaborators

  • Wuhan Asia Heart Hospital

    lead OTHER

Principal Investigators

  • Zhenlu ZHANG, MD,PhD · Wuhan Asia Heart Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2023-12-01
Completion
2023-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03261284 on ClinicalTrials.gov